Format

Send to

Choose Destination

See 1 citation:

Nat Rev Clin Oncol. 2015 Feb;12(2):73-4. doi: 10.1038/nrclinonc.2014.233. Epub 2015 Jan 6.

Colorectal cancer in 2014: progress in defining first-line and maintenance therapies.

Author information

1
Division of Medical Oncology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.

Abstract

The results of several clinical trials in metastatic colorectal cancer presented in 2014 will influence clinical practice. These findings include definitive data from phase III trials comparing bevacizumab and cetuximab-based therapy in the first-line, studies elucidating the value of maintenance therapy after induction treatment, and data on new agents in this disease.

PMID:
25560533
DOI:
10.1038/nrclinonc.2014.233
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Nature Publishing Group
Loading ...
Support Center